Pharmatech Associates today announced the promotion of Mustafa Abdallah to the position of vice president, regulatory compliance, from his previous role as director. Mr. Abdallah works with a broad array of life science organizations, drug and device sponsors, and contract manufacturing solution providers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200120005015/en/
Mustafa Abdallah, Vice President, Regulatory Compliance at Pharmatech Associates (Photo: Business Wire)
“Pharmatech has assembled one of the most diverse professional teams in the industry, and I am particularly pleased when our associates produce results leading to promotion to our Executive Leadership Team,” said Warren Baker, chief executive officer, Pharmatech Associates. “Mustafa’s outstanding personal character, technical excellence, and influential leadership qualities embody the very definition of a trusted advisor, dedicated to solving the global regulatory problems our clients face.”
Mr. Abdallah brings over 20 years of experience in computer systems validation (CSV), design and deployment of quality management systems (QMS), IT operations and financial security systems within regulated life sciences environments. He holds a bachelor of science in analytical chemistry from California State University, Fresno, and a MBA from California State University, East Bay.
About Pharmatech Associates
Pharmatech Associates is a global consultancy for the life science industry, meeting the complex needs of clients with highly experienced scientists and engineering subject matter experts. Pharmatech’s team specializes in Product and Process Development, Facilities and Capital Projects, Regulatory Compliance, and Regulatory Affairs. Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in Asia, Europe and North America from its headquarters in the San Francisco Bay Area. https://pharmatechassociates.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200120005015/en/
